Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Mayr

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Gastroenterology|June 27, 2022
ReplyJulian Schwärzler, Lisa Mayr, Timon E Adolph
Paediatric Drugs|October 21, 2025
Medulloblastoma: Current Standard of Care and Future Treatment OpportunitiesLisa Mayr, Amedeo A Azizi, Johannes Gojo, et al.
Current Pharmaceutical Design|March 29, 2018
Paneth Cells and their Antimicrobials in Intestinal ImmunityTimon E Adolph, Lisa Mayr, Felix Grabherr, et al.
Trends in Cell Biology|February 10, 2024
Epithelial metabolism as a rheostat for intestinal inflammation and malignancyJulian Schwärzler, Lisa Mayr, Felix Grabherr, et al.
Annual Review of Nutrition|August 22, 2019
Pancreas-Microbiota Cross Talk in Health and DiseaseTimon E Adolph, Lisa Mayr, Felix Grabherr, et al.
Antimicrobial Agents and Chemotherapy|October 11, 2017
Impact of Morphological Sectors on Antifungal Susceptibility Testing and Virulence StudiesEmina Jukic, Michael Blatzer, Ulrike Binder, et al.
Nature Reviews. Gastroenterology & Hepatology|July 29, 2022
The metabolic nature of inflammatory bowel diseasesTimon E Adolph, Moritz Meyer, Julian Schwärzler, et al.
Journal of Obesity|December 12, 2018
Weight Loss Induced by Bariatric Surgery Restricts Hepatic <i>GDF15</i> ExpressionTimon E Adolph, Felix Grabherr, Lisa Mayr, et al.
Acta Neuropathologica Communications|June 5, 2020
Cerebrospinal fluid penetration of targeted therapeutics in pediatric brain tumor patientsArmin Sebastian Guntner, Andreas Peyrl, Lisa Mayr, et al.
Oncotarget|January 27, 2018
CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft modelLisa Mayr, Christine Pirker, Daniela Lötsch, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Gastroenterology|June 27, 2022
ReplyJulian Schwärzler, Lisa Mayr, Timon E Adolph
Paediatric Drugs|October 21, 2025
Medulloblastoma: Current Standard of Care and Future Treatment OpportunitiesLisa Mayr, Amedeo A Azizi, Johannes Gojo, et al.
Current Pharmaceutical Design|March 29, 2018
Paneth Cells and their Antimicrobials in Intestinal ImmunityTimon E Adolph, Lisa Mayr, Felix Grabherr, et al.
Trends in Cell Biology|February 10, 2024
Epithelial metabolism as a rheostat for intestinal inflammation and malignancyJulian Schwärzler, Lisa Mayr, Felix Grabherr, et al.
Annual Review of Nutrition|August 22, 2019
Pancreas-Microbiota Cross Talk in Health and DiseaseTimon E Adolph, Lisa Mayr, Felix Grabherr, et al.
Antimicrobial Agents and Chemotherapy|October 11, 2017
Impact of Morphological Sectors on Antifungal Susceptibility Testing and Virulence StudiesEmina Jukic, Michael Blatzer, Ulrike Binder, et al.
Nature Reviews. Gastroenterology & Hepatology|July 29, 2022
The metabolic nature of inflammatory bowel diseasesTimon E Adolph, Moritz Meyer, Julian Schwärzler, et al.
Journal of Obesity|December 12, 2018
Weight Loss Induced by Bariatric Surgery Restricts Hepatic <i>GDF15</i> ExpressionTimon E Adolph, Felix Grabherr, Lisa Mayr, et al.
Acta Neuropathologica Communications|June 5, 2020
Cerebrospinal fluid penetration of targeted therapeutics in pediatric brain tumor patientsArmin Sebastian Guntner, Andreas Peyrl, Lisa Mayr, et al.
Oncotarget|January 27, 2018
CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft modelLisa Mayr, Christine Pirker, Daniela Lötsch, et al.
Pageof 7